Neuroleptic malignant syndrome induced by metoclopramide
- PMID: 1820178
- DOI: 10.1016/0753-3322(91)90048-x
Neuroleptic malignant syndrome induced by metoclopramide
Abstract
Neuroleptic malignant syndrome (NMS) associated with metoclopramide is rare. NMS probably results from neuroleptic-induced dopamine receptor blockade. We describe a case and have found only seven reports of metoclopramide-induced NMS in the literature.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources